Semler Scientific (NASDAQ:SMLR) reported Q1 EPS of $0.41, $0.07 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $14 million versus the consensus estimate of $14.51 million.
Semler Scientific (NASDAQ:SMLR) reported Q1 EPS of $0.41, $0.07 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $14 million versus the consensus estimate of $14.51 million.